Metraipolis › archive › dc_eeae3357c5ac

Comparison of anti-PD-1/PD-L1-based regimens in relapsed/refractory diffuse large B-cell lymphoma: a meta-analysis — Europe PMC PMID:41282995

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41282995
DOI
10.7717/peerj.20314
License (as archived)
solo-consultazione
Archived
2026-11-08T10:19:25.725Z
SHA-256 of the archived text
ac73fade2457caf9ef1b94def99ead8f801be4d3e08041f538389b33db7f5e5c
Stable URL of this page
https://metraipolis.com/documento/dc_eeae3357c5ac

How to cite

Comparison of anti-PD-1/PD-L1-based regimens in relapsed/refractory diffuse large B-cell lymphoma: a meta-analysis — Europe PMC PMID:41282995 — Europe PMC (en), https://europepmc.org/article/MED/41282995 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eeae3357c5ac (Metraipolis archive dc_eeae3357c5ac, sha256 ac73fade2457caf9ef1b94def99ead8f801be4d3e08041f538389b33db7f5e5c)
BibTeX
@misc{dceeae3357c5ac,
  title = {Comparison of anti-PD-1/PD-L1-based regimens in relapsed/refractory diffuse large B-cell lymphoma: a meta-analysis — Europe PMC PMID:41282995},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41282995},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eeae3357c5ac; sha256 ac73fade2457caf9ef1b94def99ead8f801be4d3e08041f538389b33db7f5e5c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41282995. Agents can read the archived copy with the MCP tool read_document.